NBY

#4322
NovaBay Pharmaceuticals, Inc.
1.9500 USD
+21.50%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
1.9300
1.9800
Year Range
0.4673
2.8000
Daily Change
+21.50%
Monthly Change
+60.89%
6 month change
+306.17%
Year Change
+306.17%
Previous Close
1.6050
Open
1.9490
Low
1.9300
High
1.9800
Volume
152
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization 51.9188 M
  • Employee 4
  • Founded 2000
  • CEO N/A
  • Website www.novabay.com
  • Headquarter Delaware, United States
  • FIGI BBG000PVPJT3
  • Industry Biotechnology

NovaBay Pharmaceuticals Inc

NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on products for eye care. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis. and NeutroPhase, used in treatment of Necrotizing Fasciitis

News